IL118162A - Pharmaceutical compositions for oral administration containing nanoparticles of active agent and solubilizing agent - Google Patents

Pharmaceutical compositions for oral administration containing nanoparticles of active agent and solubilizing agent

Info

Publication number
IL118162A
IL118162A IL11816296A IL11816296A IL118162A IL 118162 A IL118162 A IL 118162A IL 11816296 A IL11816296 A IL 11816296A IL 11816296 A IL11816296 A IL 11816296A IL 118162 A IL118162 A IL 118162A
Authority
IL
Israel
Prior art keywords
pharmaceutical composition
composition according
daim
polymer
active agent
Prior art date
Application number
IL11816296A
Other languages
English (en)
Other versions
IL118162A0 (en
Original Assignee
Novartis Ag
Gurny Robert
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Gurny Robert filed Critical Novartis Ag
Publication of IL118162A0 publication Critical patent/IL118162A0/xx
Publication of IL118162A publication Critical patent/IL118162A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL11816296A 1995-05-08 1996-05-06 Pharmaceutical compositions for oral administration containing nanoparticles of active agent and solubilizing agent IL118162A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95810306 1995-05-08

Publications (2)

Publication Number Publication Date
IL118162A0 IL118162A0 (en) 1996-09-12
IL118162A true IL118162A (en) 2001-10-31

Family

ID=8221740

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11816296A IL118162A (en) 1995-05-08 1996-05-06 Pharmaceutical compositions for oral administration containing nanoparticles of active agent and solubilizing agent

Country Status (13)

Country Link
EP (1) EP0835103B1 (ja)
JP (1) JP4128621B2 (ja)
AR (1) AR002049A1 (ja)
AT (1) ATE297195T1 (ja)
AU (1) AU5811996A (ja)
CA (1) CA2219777C (ja)
DE (1) DE69634818T2 (ja)
ES (1) ES2243952T3 (ja)
IL (1) IL118162A (ja)
PT (1) PT835103E (ja)
TW (1) TW493991B (ja)
WO (1) WO1996035414A1 (ja)
ZA (1) ZA963584B (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045829A (en) * 1997-02-13 2000-04-04 Elan Pharma International Limited Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
FR2766368B1 (fr) * 1997-07-24 2000-03-31 Univ Claude Bernard Lyon Procede de preparation de nanocapsules de type vesiculaire, utilisables notamment comme vecteurs colloidaux de principes actifs pharmaceutiques ou autres
EP0901786B1 (en) 1997-08-11 2007-06-13 Pfizer Products Inc. Solid pharmaceutical dispersions with enhanced bioavailability
US6350786B1 (en) 1998-09-22 2002-02-26 Hoffmann-La Roche Inc. Stable complexes of poorly soluble compounds in ionic polymers
SA99191255B1 (ar) 1998-11-30 2006-11-25 جي دي سيرل اند كو مركبات سيليكوكسيب celecoxib
DE60124080T2 (de) * 2000-03-23 2007-03-01 Elan Pharmaceuticals, Inc., San Francisco Verbindungen und verfahren zur behandlung der alzheimerschen krankheit
GB0216700D0 (en) 2002-07-18 2002-08-28 Astrazeneca Ab Process
GB0302673D0 (en) 2003-02-06 2003-03-12 Astrazeneca Ab Pharmaceutical formulations
ATE544447T1 (de) 2003-09-26 2012-02-15 Alza Corp Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
US8541026B2 (en) 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
EP1923051A4 (en) * 2005-09-06 2012-12-19 Astellas Pharma Inc MICROPARTICLES OF A HEAVY-DUTY SUBSTANCE WITH ENTERIAN BASE MATERIAL ADSORBED ON THE SUBSTANCE SURFACE
US20090004231A1 (en) 2007-06-30 2009-01-01 Popp Shane M Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
TW200946266A (en) * 2008-02-27 2009-11-16 Kuraray Co Method of manufacturing metalnanowire and dispersion medium comprising the resultant metalnanowire, and transparent conductive film
WO2010084088A2 (en) 2009-01-21 2010-07-29 Basf Se Starch nanoparticles for drug delivery systems
WO2010084060A1 (en) 2009-01-21 2010-07-29 Basf Se Starch copolymers and nanoparticles thereof for drug delivery systems
GB201006038D0 (en) 2010-04-12 2010-05-26 Unilever Plc Improvements relating to antiviral compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
US5382435A (en) * 1993-03-24 1995-01-17 Southwest Research Institute Microparticulate pharmaceutical delivery system

Also Published As

Publication number Publication date
JP4128621B2 (ja) 2008-07-30
DE69634818T2 (de) 2006-03-23
AR002049A1 (es) 1998-01-07
CA2219777C (en) 2007-06-12
DE69634818D1 (de) 2005-07-14
EP0835103A1 (en) 1998-04-15
WO1996035414A1 (en) 1996-11-14
IL118162A0 (en) 1996-09-12
ZA963584B (en) 1996-11-08
AU5811996A (en) 1996-11-29
ES2243952T3 (es) 2005-12-01
ATE297195T1 (de) 2005-06-15
JPH11504638A (ja) 1999-04-27
CA2219777A1 (en) 1996-11-14
TW493991B (en) 2002-07-11
EP0835103B1 (en) 2005-06-08
PT835103E (pt) 2005-10-31

Similar Documents

Publication Publication Date Title
US20070275969A1 (en) Nanoparticles for oral administration of pharmaceutical agents of low solubility
CA2219777C (en) Nanoparticles for oral administration of pharmaceutical agents of low solubility
JP3734279B2 (ja) フレーバーマスクされた薬学的組成物
AU2003246792B2 (en) Oral suspension of active principle microcapsules
CN103120653B (zh) 一种口服药物组合物
US8273375B2 (en) Multiparticle pharmaceutical dosage form for a low-soluble active substances and method for producing said pharmaceutical dosage form
CA2113243C (en) Pharmaceutical compositions containing nanocapsules
AU2003269068A1 (en) Micropcapsules with modified release of active principles with low solubility for oral delivery
AU2003269067A1 (en) Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with low solubility
WO1997010811A1 (en) Nanoparticles in photodynamic therapy
US20060159758A1 (en) Coating composition for taste masking coating and methods for their application and use
Oppenheim Nanoparticulate drug delivery systems based on gelatin and albumin
JPH0451528B2 (ja)
JP4723243B2 (ja) ペリンドプリルの遅延及び制御放出のためのマイクロカプセル
ZA200407594B (en) Oral suspension of active principle microcapsules

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees